Loading…
Simultaneous diagnostic platform of genotyping EGFR, KRAS, and ALK in 510 Korean patients with non-small-cell lung cancer highlights significantly higher ALK rearrangement rate in advanced stage
Background Simultaneous genotyping has advantages in turnaround time and detecting the real mutational prevalence in unresectable non‐small‐cell lung cancer (NSCLC), a group not previously genetically characterized. Methods We developed simultaneous panel of screening EGFR and KRAS mutations by dire...
Saved in:
Published in: | Journal of surgical oncology 2014-09, Vol.110 (3), p.245-251 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Simultaneous genotyping has advantages in turnaround time and detecting the real mutational prevalence in unresectable non‐small‐cell lung cancer (NSCLC), a group not previously genetically characterized.
Methods
We developed simultaneous panel of screening EGFR and KRAS mutations by direct sequencing or PNA clamping, and ALK rearrangement by fluorescent in situ hybridization (FISH) in multicenter manner.
Results
Of 510 NSCLC Korean patients, simultaneous genotyping identified mutations of EGFR (29.0%) and KRAS (8.6%) and rearrangement of ALK (9.2%). Seven patients had overlaps in mutations. Although several well‐known associations between genotypes and clinical characteristics were identified, we found no relationship between ALK rearrangement and sex or smoking history. Unlike the other genotype mutations, ALK rearrangement was associated with advanced disease. Among the ALK‐negative group, patients with 10–15% of ALK FISH split shared characteristics, such as younger age and advanced stage disease, more with the ALK‐positive group (>15% ALK FISH split) than |
---|---|
ISSN: | 0022-4790 1096-9098 |
DOI: | 10.1002/jso.23646 |